EUVIMED · CrossrefZeitschrift
Journal of Urology
ISSN 0022-5347 · Ovid Technologies (Wolters Kluwer Health)
Neueste Artikel
Male Infertility
Endourology and Nephrolithiasis
What Amazon Knows That Medicine Does Not: Behavioral Economics and Patient Adherence
Trauma, and Genital and Urethral Reconstruction
Microplastics in Urinary Calculi: Evidence From Human Urinary Stones
Letter: Advanced Prostate Cancer: AUA/SUO Guideline Amendment (2026) Part I: Evaluation and Treatment of Biochemically Recurrent (Following Exhaustion of Local Therapy) and Metastatic Hormone-Sensitive Prostate Cancer
Quality of Life Improves With Improved Continence in People With Spina Bifida
Are Biological Doublets the Future of Adjuvant Therapy After Surgery for Renal Cell Carcinoma?
Second Time's a Charm? A Matched Case-Control Analysis of Revision Urethroplasty vs Primary Urethroplasty
IP47-13 UCIPredict: Liquid Biopsy-Based Prediction of Immunotherapy Response in Urothelial Carcinoma—Interim Multicenter Results: Erratum
Uro-Science
Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology
Letter: The Effect of Prostate Volume and 5-Alpha Reductase Inhibitor Use on Grade Progression and Treatment Decisions in Patients With Prostate Cancer on Active Surveillance
Editorial Comment
Editorial Comment
Beyond the NMIBC-MIBC Dichotomy: Integrating Molecular Biomarkers Into Bladder Cancer Risk Stratification
Reply: Advanced Prostate Cancer: AUA/SUO Guideline Amendment (2026) Part I: Evaluation and Treatment of Biochemically Recurrent (Following Exhaustion of Local Therapy) and Metastatic Hormone-Sensitive Prostate Cancer
Cost-Effectiveness of Immune Checkpoint Inhibitor Therapy Plus Bacillus Calmette-Guérin for High-Risk Nonmuscle-Invasive Bladder Cancer: Analyses of CREST, POTOMAC, and ALBAN: Erratum
Postdiagnostic Red Meat, Poultry, and Egg Intake and Risk of Prostate Cancer Progression and Mortality: A Systematic Review
Letter: Urine Tumor DNA Testing Identifies Recurrence and Monitors Therapy Response in Patients With High-Risk Nonmuscle-Invasive Bladder Cancer Receiving Intravesical Bacillus Calmette-Guérin
Efficacy, Safety, and Biomarker Analysis of Toripalimab Monoclonal Antibody Combined With Gemcitabine and Cisplatin Chemotherapy as Neoadjuvant Treatment in Muscle-Invasive Bladder Cancer: A Phase II Clinical Trial: Erratum
Letter: Quality of Life Improves With Improved Continence in People With Spina Bifida
A Phenotype-Guided Approach to Lower Urinary Tract Symptom Management: Strategies From MAPP and LURN Research Networks
Vitamin D for Bedwetting: Promise and Precautions
Navigating the New Landscape: A Clinical Commentary on the 2026 AUA Guideline on Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia
Medical Management of Kidney Stones in 2026: What Has Changed Since 2014?
Letter: Noninvasive Urine Test Predicts Grade Group Upgrading in Patients on Active Surveillance for Prostate Cancer: Multisite Validation and Comparison With MRI
Reply by Authors
Editorial Comment
Letter: sPaRT2—Minimally Invasive Partial vs Radical Nephrectomy for cT2 Renal Cell Carcinoma: A National Matched-Pair Analysis (UroCCR 235)
Jahrgänge
2026 · 3.8092025 · 3.2992024 · 3.3072023 · 3.2852022 · 3.1062021 · 3.5332020 · 4.2412019 · 4.1342018 · 4.2202017 · 4.5832016 · 4.2642015 · 4.0792014 · 3.7162013 · 3.9772012 · 4.0062011 · 4.1392010 · 3.6372009 · 4.0542008 · 3.9432007 · 3.6862006 · 3.7612005 · 3.5952004 · 3.7712003 · 1.8402002 · 3.1362001 · 2.6072000 · 2.4661999 · 4.6811998 · 3.4671997 · 2.4931996 · 2.6961995 · 2.3201994 · 1.2591993 · 1.1561992 · 1.2941991 · 1.0201990 · 1.1041989 · 1.4681988 · 1.5041987 · 2.651
EUVIMED